phase 2_completion
saveUniversity of Minnesota — Lactobacillus casei (Phase II Trial Completion)
community read0 votes
Therapy area: Musculoskeletal Disorders. Indication: Muscle Injury, Unspecified Musculoskeletal Disorders
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- grantUNIVERSITY OF MINNESOTA — Technology Development for Whole Brain Functional and Structural Connectivity...Apr 10, 2026
- grantUNIVERSITY OF MINNESOTA — Development of broadly protective Lassa vaccines using the Pichinde virus vectorApr 9, 2026
- grantUNIVERSITY OF MINNESOTA — Targeting oncogenic KRAS to sensitize pancreatic cancer to NK cell immunotherapyApr 9, 2026
- grantUNIVERSITY OF MINNESOTA — Technology-Enhanced Adherence to Medication intervention for youth with Type ...Apr 1, 2026
- grantUNIVERSITY OF MINNESOTA — Safe, effective, and trustworthy AI for healthcare delivery organizations and...Apr 1, 2026
- grantUNIVERSITY OF MINNESOTA — Cell Context and Variant Effects: Multiplexed Assays for Synthetic Protein In...Apr 1, 2026
comments(0)
5-min edit window · permanent after that